Skip to main content

Staff Profile

Professor Camille Carroll

Professor of Clinical Neuroscience

  • Email: camille.carroll@ncl.ac.uk
  • Address: Translational and Clinical Research Institute
    Faculty of Medical Sciences
    Newcastle University
    Clinical Ageing Research Unit
    Campus for Ageing and Vitality
    Newcastle upon Tyne
    NE4 5PL
Background

I am Professor of Clinical Neuroscience at the Translational and Clinical Research Institute at Newcastle and Faculty of Health, University of Plymouth. I am Honorary Consultant Neurologist at University Hospitals Plymouth NHS Trust. I undertook preclinical medical training at the University of Manchester, where I also completed an intercalated PhD (1994) investigating NMDA receptor antagonists in models of Parkinson's disease (PD). I completed clinical training at the University of Oxford in 1997 and undertook specialist neurology training in the South West and West Midlands. I was awarded an MRC post-doctoral clinical research training fellowship in 2007, enabling me to develop my research interest in investigating neuroprotection in Parkinson's disease. 


I am the NIHR Clinical Research Network National Specialty Lead for Neurodegenerative Diseases, overseeing a balanced clinical trial portfolio in neurodegenerative disorders and lead the NIHR Remote Methods of Trial Delivery project. I am Clinical co-Director of the Parkinson’s Excellence Network in the UK and have been internationally recognized for my patient-centred approach, broadening the opportunity for Parkinson’s research and improving support for patient care and self-management.


Within University Hospitals Plymouth NHS Trust, I led the development of the Parkinson’s disease service, which won Parkinson's Excellence Network Awards in 2017 and 2019, and BMJ Award Highly Commended for Digital Innovation in 2021.


I co-chair the international Linked Clinical Trials Committee (Cure Parkinson's), am a member of the College of Experts (Parkinson's UK) and am Associate Editor Journal of Parkinson's Disease.

Research

My research is focused on disease modification and the use of digital health technologies for monitoring and personalised care in Parkinson’s. I was the chief investigator of a multi-centre clinical trial of simvastatin as a disease modifying agent in Parkinson’s disease (PD STAT), and am a co-investigator of the Exenatide-PD3 trial. One of my major interests is innovation in trial design and delivery, aiming to increase efficiency and ensure that trials are more inclusive of under-served populations. With Prof. Tom Foltynie (UCL), I co-lead the the Edmond J Safra ACT-PD initiative, a multi-professional consortium developing a multi-arm, multi-stage trial platform for disease modifying interventions in Parkinson’s, which will transform the disease-modifying trial landscape in the UK.


In collaboration with Prof. Edward Meinert, I am creating digital tools to support patient self-management and digitally-enabled care, embedded in innovative care pathways that have been co-created with patients and multiple professionals. The development, iteration and evaluation of these novel approaches to care will enable translation to other long-term conditions and neurodegenerative diseases.


I act as principal and UK lead investigator for commercial interventional trials in Parkinson's disease, and am a member/chair of several trial steering and data monitoring committees.







Publications

  • Articles

    • Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, Aslibekyan S, Auton A, Babalola E, Bell RK, Bielenberg J, Bryc K, Bullis E, Cannon P, Coker D, Partida GC, Dhamija D, Das S, Elson SL, Eriksson N, Filshtein T, Fitch A, Fletez-Brant K, Fontanillas P, Freyman W, Granka JM, Hernandez A, Hicks B, Hinds DA, Jewett EM, Jiang Y, Kukar K, Kwong A, Lin K-H, Llamas BA, Lowe M, McCreight JC, McIntyre MH, Micheletti SJ, Moreno ME, Nandakumar P, Nguyen DT, Noblin ES, O'Connell J, Petrakovitz AA, Poznik GD, Reynoso A, Schloetter M, Schumacher M, Shastri AJ, Shelton JF, Shi J, Shringarpure S, Su QJ, Tat SA, Tchakoute CT, Tran V, Tung JY, Wang X, Wang W, Weldon CH, Wilton P, Wong CD, Iwaki H, Lake J, Solsberg CW, Leonard H, Makarious MB, Tan E-K, Singleton AB, Bandres-Ciga S, Noyce AJ, Gatto EM, Kauffman M, Khachatryan S, Tavadyan Z, Shepherd CE, Hunter J, Kumar K, Ellis M, Renteria ME, Koks S, Zimprich A, Schumacher-Schuh AF, Rieder C, Awad PS, Tumas V, Camargos S, Fon EA, Monchi O, Fon T, Galleguillos BP, Miranda M, Bustamante ML, Olguin P, Chana P, Tang B, Shang H, Guo J, Chan P, Luo W, Arboleda G, Orozc J, del Rio MJ, Hernandez A, Salama M, Kamel WA, Zewde YZ, Brice A, Corvol J-C, Westenberger A, Illarionova A, Mollenhauer B, Klein C, Vollstedt E-J, Hopfner F, Hoglinger G, Madoev H, Trinh J, Junker J, Lohmann K, Lange LM, Sharma M, Groppa S, Gasser T, Fang Z-H, Akpalu A, Xiromerisiou G, Hadjigorgiou G, Dagklis I, Tarnanas I, Stefanis L, Stamelou M, Dadiotis E, Medina A, Chan GH-F, Ip N, Cheung NY-F, Chan P, Zhou X, Kishore A, Divya KP, Pal P, Kukkle PL, Rajan R, Borgohain R, Salari M, Quattrone A, Valente EM, Parnetti L, Avenali M, Schirinzi T, Funayama M, Hattori N, Shiraishi T, Karimova A, Kaishibayeva G, Shambetova C, Kruger R, Tan AH, Ahmad-Annuar A, Norlinah MI, Murad NAA, Azmin S, Lim S-Y, Mohamed W, Tay YW, Martinez-Ramirez D, Rodriguez-Violante M, Reyes-Perez P, Tserensodnom B, Ojha R, Anderson TJ, Pitcher TL, Sanyaolu A, Okubadejo N, Ojo O, Aasly JO, Pihlstrom L, Tan M, Ur-Rehman S, Veliz-Otani D, Cornejo-Olivas M, Doquenia ML, Rosales R, Vinuela A, Iakovenko E, Mubarak BA, Umair M, Amod F, Carr J, Bardien S, Jeon B, Kim YJ, Cubo E, Alvarez I, Hoenicka J, Beyer K, Perinan MT, Pastor P, El-Sadig S, Brolin K, Zweier C, Tinkhauser G, Krack P, Lin C-H, Wu H-C, Kung P-J, Wu R-M, Wu Y, Amouri R, Sassi SB, Basak AN, Genc G, Cakmak OO, Ertan S, Martinez-Carrasco A, Schrag A, Schapira A, Carroll C, Bale C, Grosset D, Stafford EJ, Houlden H, Morris HR, Hardy J, Mok KY, Rizig M, Wood N, Williams N, Okunoye O, Lewis PA, Kaiyrzhanov R, Weil R, Love S, Stott S, Jasaityte S, Dey S, Obese V, Espay A, O'Grady A, Sobering AK, Siddiqi B, Casey B, Fiske B, Jonas C, Cruchaga C, Pantazis CB, Comart C, Wegel C, Hall D, Hernandez D, Shiamim E, Riley E, Faghri F, Serrano GE, Chen H, Mata IF, Sarmiento IJK, Williamson J, Jankovic J, Shulman J, Solle JC, Murphy K, Nuytemans K, Kieburtz K, Markopoulou K, Marek K, Levine KS, Chahine LM, Ibanez L, Screven L, Ruffrage L, Shulman L, Marsili L, Kuhl M, Dean M, Koretsky M, Puckelwartz MJ, Inca-Martinez M, Louie N, Mencacci NE, Albin R, Alcalay R, Walker R, Chowdhury S, Dumanis S, Lubbe S, Xie T, Foroud T, Beach T, Sherer T, Song Y, Nguyen D, Nguyen T, Atadzhanov M, Blauwendraat C, Nalls MA, Foo JN, Mata I. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease. Nature Genetics 2024, 56(1), 27-36.
    • Gonzalez-Robles C, Weil RS, Van Wamelen D, Bartlett M, Burnell M, Clarke CS, Hu MT, Huxford B, Jha A, Lambert C, Lawton M, Mills G, Noyce A, Piccini P, Pushparatnam K, Rochester L, Siu C, Williams-Gray CH, Zeissler M-L, Zetterberg H, Carroll CB, Foltynie T, Schrag A. Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative. Journal of Parkinson's Disease 2023, 13(6), 1013-1035.
    • Zeissler M-L, Boey T, Chapman D, Rafaloff G, Dominey T, Raphael KG, Buff S, Pai HV, King E, Sharpe P, O'Brien F, Carroll CB. Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol. BMJ Open 2023, 13(12), e071641.
    • Chapman R, Zeissler M-L, Meinert E, Mullin S, Whipps S, Whipps J, Hockey K, Hockey P, Carroll CB. Incorporating usability evaluation into iterative development of an online platform to support research participation in Parkinson's disease: A mixed methods protocol. BMJ Open 2023, 13(12), e078638.
    • Hall AM, Aroori S, Carroll CB, Meinert E, Allgar V. Impact of digital technologies on self-efficacy in people with Parkinson's: a scoping review protocol. BMJ Open 2023, 13(3), e069929.
    • Rizig M, Bandres-Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, Levine KS, Abubakar SA, Achoru CO, Vitale D, Adeniji OA, Agabi OP, Koretsky MJ, Agulanna U, Hall DA, Akinyemi RO, Xie T, Ali MW, Shamim EA, Ani-Osheku I, Padmanaban M, Arigbodi OM, Standaert DG, Bello AH, Dean MN, Erameh CO, Elsayed I, Farombi TH, Okunoye O, Fawale MB, Billingsley KJ, Imarhiagbe FA, Jerez PA, Iwuozo EU, Baker B, Komolafe MA, Malik L, Nwani PO, Daida K, Nwazor EO, Miano-Burkhardt A, Nyandaiti YW, Fang Z-H, Obiabo YO, Kluss JH, Odeniyi OA, Hernandez DG, Odiase FE, Tayebi N, Ojini FI, Sidranksy E, Onwuegbuzie GA, D'Souza AM, Osaigbovo GO, Berhe B, Osemwegie N, Reed X, Oshinaike OO, Leonard HL, Otubogun FM, Alvarado CX, Oyakhire SI, Ozomma SI, Samuel SC, Taiwo FT, Wahab KW, Zubair YA, Iwaki H, Kim JJ, Morris HR, Hardy J, Heilbron K, Norcliffe-Kaufmann L, Okubadejo N, Ojo O, Abiodun O, Achoru C, Agabi O, Akinyemi R, Ali M, Arigbodi O, Bello A, Erameh C, Farombi T, Fawale M, Imarhiagbe F, Iwuozo E, Komolafe M, Nwani P, Nwazor E, Nyandaiti Y, Obiabo Y, Odeniyi O, Odiase F, Ojini F, Onwuegbuzie G, Osaigbovo G, Oshinaike O, Otubogun F, Oyakhire S, Ozomma S, Samuel S, Taiwo F, Wahab K, Zubair Y, Gams Massi D, Gueumekane Bila lamou E, Njamnshi Nfor L, Magnerou MA, Fogang Fogoum Y, Shalash A, El-FawaI H, Khedr E, Fawi G, A Eltantawi M, Salama M, El-Jaafary S, Hamed S, Tafesse Mengesha A, Alemayehu Ayele B, Melka Oda D, Zenebe Zewde Y, Debebe Gelan Y, AkpaIu A, Charway-Felli A, Stephen Sarfo F, Adjei P, Obese V, Bocoum A, Koita A, Oumar Guinto C, Coulibaly T, Maiga Y, Kone Z, Bell A, Adebowale AA, Akpekpe J, lyagba A, Wulgo AM, Arabambi B, Agu C, Dike F, Ishola I, Abiodun K, Ekenze O, Agabi Osigwe P, Balarabe S, Abubakar S, Williams U, Fall M, Mamadou Diop A, Hilaire Dominique ET, Mochan A, Modi G, Dindayal S, Ali Awadelkareem E, Dahawi M, Awadelkareem MA, Misbah S, Mushengez B, Kimambo H, Msango L, Adebayo P, OKeng K, Diekker M, URassa S, Gouider R, Ben Djebara M, Gargouri A, Kacem I, Nasri A, Mrabet S, Sghaier I, Mkada I, Atadzhanov M, Chishimba L, Jama F, Houlden H, Singleton A, Nalls M, Shamim E, Jonas C, Williamson J, Hall DA, Rosenbaum M, Davis S, Dean M, Cromer C, Smith J, Ruffrage L, Richardson J, Sipma R, Padmanaban M, Warren N, Mercado T, Disbrow E, Chauppeta B, Thomas-Dean F, Toms J, Lofton K, Rawls A, Rizer K, Black N, Solle J, O'Grady A, Sherer T, Fiske B, Blauwendraat C, Okubadejo NU, Basak AN, Tan AH, Noyce A, Akpalu A, Espay A, Martinez-Carrasco A, Medina A, Zimprich A, Brice A, Karimova A, Hernandez A, Illarionova A, Quattrone A, Singleton AB, Sobering AK, Vinuela A, Sanyaolu A, Schumacher-Schuh AF, Kishore A, Ahmad-Annuar A, Al Mubarak B, Tang B, Pizarro Galleguillos B, Jeon B, Siddiqi B, Casey B, Mollenhauer B, Carroll C, Rieder C, Pantazis CB, Comart C, Lin C-H, Klein C, Bale C, Shepherd CE, Wegel C, Martinez-Ramirez D, Hall D, Hernandez D, KP D, Nguyen D, Fon EA, Dadiotis E, Riley E, Iakovenko E, Stafford E, Gatto EM, Valente EM, Vollstedt E-J, Faghri F, Genc G, Xiromerisiou G, Hadjigorgiou G, Hiu-Fai Chan G, Arboleda G, Kaishibayeva G, Hoglinger G, Leonard H, Madoev H, Chen H, Wu H-C, Shang H, F Mata I, Keller Sarmiento IJ, Dagklis I, Tarnanas I, Aasly JO, Hoenicka J, Corvol J-C, Foo JN, Guo J, Junker J, Carr J, Kim JJ, Orozco J, Jankovic J, Shulman J, Hunter J, Solle JC, Murphy K, Nuytemans K, Kieburtz K, Lohmann K, Marek K, Mok KY, Kumar K, Levine K, Chahine LM, Lange LM, Pihlstrom L, Screven L, Stefanis L, Shulman L, Marsili L, Parnetti L, Kuhl M, Funayama M, Sharma M, Tan M, Kauffman M, Miranda M, Bustamante ML, Stamelou M, Perinan Tocino MT, Cornejo-Olivas M, Jimenez del Rio M, Koretsky M, Rodriguez-Violante M, Ellis M, Avenali M, Renteria ME, Inca-Martines MZ, Nalls MA, Nalls MA, Ibrahim Norlinah M, Umair M, Ip N, Louie N, Cheung NY-F, Mencacci NE, Wood N, Williams N, Hattori N, Abdul Murad NA, Ibrahim NM, Monchi O, Oztop Cakmak O, Oztop Cakmak POC, Lewis PA, Pastor P, Reyes-Perez P, Saffie Awad P, Chana P, Chan P, Kung P-J, Chan P, Pal P, Lingappa Kukkle P, Ojha R, Kaiyrzhanov R, Kruger R, Amouri R, Weil R, Rajan R, Alcalay R, Wu R-M, Borgohain R, Sassi SB, Khachatryan S, El-Sadig S, Wu S, Groppa S, Azmin S, Lim S-Y, Ur-Rehman S, Ertan S, Stott S, Jasaitye S, Chowdhury S, Dumanis S, Bardien S, Lubbe S, Koks S, Dey S, Foroud T, Fon T, Beach T, Gasser T, Anderson T, Nguyen T, Schirinzi T, Shiraishi T, Pitcher T, Tumas V, Mohamed W, Kamel WA, Luo W, Zhou X, Zewde YZ, Song Y, Wen Y, Wu Y, Joong Kim Y, Tavadyan Z. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. The Lancet Neurology 2023, 22(11), 1015-1025.
    • Gonzalez-Robles C, Bartlett M, Burnell M, Clarke CS, Haar S, Hu MT, Huxford B, Jha A, Lawton M, Noyce A, Piccini P, Pushparatnam K, Rochester L, Siu C, van Wamelen D, Williams-Gray CH, Zeissler M-L, Zetterberg H, Carroll CB, Foltynie T, Weil RS, Schrag A. Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials. Movement Disorders 2023, 39(2), 433-438.
    • Towns C, Richer M, Jasaityte S, Stafford EJ, Joubert J, Antar T, Martinez-Carrasco A, Makarious MB, Casey B, Vitale D, Levine K, Leonard H, Pantazis CB, Screven LA, Hernandez DG, Wegel CE, Solle J, Nalls MA, Blauwendraat C, Singleton AB, Tan MMX, Iwaki H, Morris HR, Gatto EM, Kauffman M, Khachatryan S, Tavadyan Z, Shepherd CE, Hunter J, Kumar K, Ellis M, Renteria ME, Koks S, Zimprich A, Schumacher-Schuh AF, Rieder C, Awad PS, Tumas V, Camargos S, Fon EA, Monchi O, Fon T, Galleguillos BP, Miranda M, Bustamante ML, Olguin P, Chana P, Tang B, Shang H, Guo J, Chan P, Luo W, Arboleda G, Orozco J, del Rio MJ, Hernandez A, Salama M, Kamel WA, Zewde YZ, Brice A, Corvol J-C, Westenberger A, Illarionova A, Mollenhauer B, Klein C, Vollstedt E-J, Hopfner F, Hoglinger G, Madoev H, Trinh J, Junker J, Lohmann K, Lange LM, Sharma M, Groppa S, Gasser T, Fang Z-H, Akpalu A, Xiromerisiou G, Hadjigorgiou G, Dagklis I, Tarnanas I, Stefanis L, Stamelou M, Dadiotis E, Medina A, Chan GH-F, Ip N, Cheung NY-F, Chan P, Zhou X, Kishore A, Kp D, Pal P, Kukkle PL, Rajan R, Borgohain R, Salari M, Quattrone A, Valente EM, Parnetti L, Avenali M, Schirinzi T, Funayama M, Hattori N, Shiraishi T, Karimova A, Kaishibayeva G, Shambetova C, Kruger R, Tan AH, Ahmad-Annuar A, Norlinah MI, Murad NAA, Azmin S, Lim S-Y, Mohamed W, Tay YW, Martinez-Ramirez D, Rodriguez-Violante M, Reyes-Perez P, Tserensodnom B, Ojha R, Anderson TJ, Pitcher TL, Sanyaolu A, Okubadejo N, Ojo O, Aasly JO, Pihlstrom L, Tan M, Ur-Rehman S, Cornejo-Olivas M, Doquenia ML, Rosales R, Vinuela A, Iakovenko E, Mubarak BA, Umair M, Tan E-K, Foo JN, Amod F, Carr J, Bardien S, Jeon B, Kim YJ, Cubo E, Alvarez I, Hoenicka J, Beyer K, Perinan MT, Pastor P, El-Sadig S, Zweier C, Krack P, Lin C-H, Wu H-C, Kung P-J, Wu R-M, Wu Y, Amouri R, Sassi SB, Basak AN, Genc G, Cakmak OO, Ertan S, Noyce A, Schrag A, Schapira A, Carroll C, Bale C, Grosset D, Houlden H, Hardy J, Mok KY, Rizig M, Wood N, Williams N, Okunoye O, Lewis PA, Kaiyrzhanov R, Weil R, Love S, Stott S, Jasaitye S, Dey S, Obese V, Espay A, O'Grady A, Sobering AK, Siddiqi B, Fiske B, Jonas C, Cruchaga C, Comart C, Wegel C, Hall D, Hernandez D, Shiamim E, Riley E, Faghri F, Serrano GE, Chen H, Mata IF, Sarmiento IJK, Williamson J, Kim JJ, Jankovic J, Shulman J, Solle JC, Murphy K, Nuytemans K, Kieburtz K, Markopoulou K, Marek K, Levine KS, Chahine LM, Ibanez L, Screven L, Ruffrage L, Shulman L, Marsili L, Kuhl M, Dean M, Koretsky M, Puckelwartz MJ, Inca-Martinez M, Louie N, Mencacci NE, Albin R, Alcalay R, Walker R, Bandres-Ciga S, Chowdhury S, Dumanis S, Lubbe S, Xie T, Foroud T, Beach T, Sherer T, Song Y, Nguyen D, Nguyen T, Atadzhanov M. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2). npj Parkinson's Disease 2023, 9, 131.
    • Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurology and Therapy 2023, 12(6), 1937-1958.
    • Kelly J, Moyeed R, Carroll C, Luo S, Li X. Blood biomarker-based classification study for neurodegenerative diseases. Scientific Reports 2023, 13, 17191.
    • Bounsall K, Milne-Ives M, Hall A, Carroll C, Meinert E. Artificial Intelligence Applications for Assessment, Monitoring, and Management of Parkinson Disease Symptoms: Protocol for a Systematic Review. JMIR Research Protocols 2023, 12, e46581.
    • Zeissler M-L, McFarthing K, Raphael KG, Rafaloff G, Windle R, Carroll CB. An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease Trials. Journal of Parkinson's Disease 2023, 13(8), 1343-1356.
    • Collett J, Lawrie S, Bromley S, Harling P, Reed A, Brusco N, Coe S, Coebergh J, Carroll C, Roberts HC, Hu MT, Dawes H. A programme evaluation of 'First Steps': A peer-conceived, developed and led self-management intervention for people after a Parkinson's diagnosis. Clinical Rehabilitation 2024, 38(3), 403-413.
    • Russell J, Inches J, Carroll CB, Bergmann JHM. A modular, deep learning-based holistic intent sensing system tested with Parkinson’s disease patients and controls. Frontiers in Neurology 2023, 14, 1260445.
    • Meinert E, Milne-Ives M, Chaudhuri KR, Harding T, Whipps J, Whipps S, Carroll C. The Impact of a Digital Artificial Intelligence System on the Monitoring and Self-management of Nonmotor Symptoms in People With Parkinson Disease: Proposal for a Phase 1 Implementation Study. JMIR Research Protocols 2022, 11(9), e40317.
    • Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, Jones B, Chapman R, Cocking L, Wilks J, Webb D, Carroll C. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurology 2022, 79(12), 1232-1241.
    • Kehagia AA, North TK, Grose J, Jeffery AN, Cocking L, Chapman R, Carroll C. Enhancing Trial Delivery in Parkinson's Disease: Qualitative Insights from PD STAT. Journal of Parkinson's Disease 2022, 12(5), 1591-1604.
    • Day JO, Smith S, Noyce AJ, Alty J, Jeffery A, Chapman R, Carroll C. Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT. Journal of Parkinson's Disease 2022, 12(5), 1605-1609.
    • Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J, Serfaty MA, Lewis G. Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease. BMC Neurology 2022, 22, 474.
    • Jost ST, Visser-Vandewalle V, Rizos A, Loehrer PA, Silverdale M, Evans J, Samuel M, Petry-Schmelzer JN, Sauerbier A, Gronostay A, Barbe MT, Fink GR, Ashkan K, Antonini A, Martinez-Martin P, Chaudhuri KR, Timmermann L, Dafsari HS, Bhidayasiri R, Falup-Pecurariu C, Jeon B, Leta V, Borghammer P, Odin P, Schrag A, Storch A, Violante MR, Weintraub D, Adler C, Barone P, Brooks DJ, Brown R, Cantillon M, Carroll C, Coelho M, Henriksen T, Hu M, Jenner P, Kramberger M, Kumar P, Kurtis M, Lewis S, Litvan I, Lyons K, Martino D, Masellis M, Mochizuki H, Morley JF, Nirenberg M, Pagonabarraga J, Panicker J, Pavese N, Pekkonen E, Postuma R, Rosales R, Schapira A, Simuni T, Stocchi F, Subramanian I, Tagliati M, Tinazzi M, Toledo J, Tsuboi Y, Walker R. Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. npj Parkinson's Disease 2021, 7, 48.
    • Eke CS, Jammeh E, Li X, Carroll C, Pearson S, Ifeachor E. Early Detection of Alzheimer's Disease with Blood Plasma Proteins Using Support Vector Machines. IEEE Journal of Biomedical and Health Informatics 2021, 25(1), 218-226.

  • Conference Proceedings (inc. Abstract)

  • Notes

    • Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study (Neurology and Therapy, (2023), 12, 6, (1937-1958), 10.1007/s40120-023-00533-1). Neurology and Therapy 2023, 12(6), 1959-1960.
    • Lange LM, Ellis M, Keller Sarmiento IJ, Tan A-H, Galandra C, Roopnarain K, Solle J, Fang Z-H, Heutink P, Kumar KR, Lim S-Y, Valente EM, Nalls M, Singleton A, Mencacci N, Klein C, Gatto EM, Kauffman M, Khachatryan S, Tavadyan Z, Shepherd CE, Hunter J, Kumar K, Ellis M, Renteria ME, Koks S, Zimprich A, Schumacher-Schuh AF, Rieder C, Awad PS, Tumas V, Camargos S, Fon EA, Monchi O, Fon T, Galleguillos BP, Miranda M, Bustamante ML, Olguin P, Chana P, Tang B, Shang H, Guo J, Chan P, Luo W, Arboleda G, Orozco J, del Rio MJ, Hernandez A, Salama M, Kamel WA, Zewde YZ, Brice A, Corvol J-C, Westenberger A, Illarionova A, Illarionova A, Mollenhauer B, Klein C, Vollstedt E-J, Hopfner F, Hoglinger G, Madoev H, Madoev H, Trinh J, Junker J, Junker J, Lohmann K, Lohmann K, Lange LM, Sharma M, Groppa S, Gasser T, Fang Z-H, Akpalu A, Xiromerisiou G, Hadjigorgiou G, Dagklis I, Tarnanas I, Stefanis L, Stamelou M, Dadiotis E, Medina A, Chan GH-F, Ip N, Cheung NY-F, Chan P, Zhou X, Kishore A, Kp D, Pal P, Kukkle PL, Rajan R, Borgohain R, Salari M, Quattrone A, Valente EM, Parnetti L, Avenali M, Avenali M, Schirinzi T, Funayama M, Hattori N, Shiraishi T, Karimova A, Kaishibayeva G, Shambetova C, Kruger R, Ahmad-Annuar A, Norlinah MI, Murad NAA, Ibrahim NM, Azmin S, Lim S-Y, Mohamed W, Tay YW, Martinez-Ramirez D, Rodriguez-Violante M, Reyes-Perez P, Tserensodnom B, Ojha R, Anderson TJ, Pitcher TL, Sanyaolu A, Okubadejo N, Ojo O, Aasly JO, Pihlstrom L, Tan M, Ur-Rehman S, Cornejo-Olivas M, Doquenia ML, Rosales R, Vinuela A, Iakovenko E, Mubarak BA, Umair M, Tan E-K, Foo JN, Amod F, Carr J, Bardien S, Jeon B, Kim YJ, Cubo E, Alvarez I, Hoenicka J, Beyer K, Perinan MT, Pastor P, El-Sadig S, Zweier C, Paul K, Lin C-H, Wu H-C, Kung P-J, Wu R-M, Wu S, Wu Y, Amouri R, Sassi SB, Basak AN, Genc G, Cakmak OO, Ertan S, Noyce A, Martinez-Carrasco A, Schrag A, Schapira A, Carroll C, Bale C, Grosset D, Stafford EJ, Houlden H, Morris HR, Hardy J, Mok KY, Rizig M, Wood N, Williams N, Okunoye O, Lewis PA, Kaiyrzhanov R, Weil R, Love S, Stott S, Jasaitye S, Dey S, Obese V, Espay A, O'Grady A, Singleton AB, Sobering AK, Siddiqi B, Casey B, Fiske B, Jonas C, Cruchaga C, Pantazis CB, Comart C, Wegel C, Wegel C, Blauwendraat C, Blauwendraat C, Vitale D, Hall D, Hernandez D, Shiamim E, Riley E, Faghri F, Serrano GE, Leonard H, Iwaki H, Chen H, Mata IF, Sarmiento IJK, Williamson J, Kim JJ, Jankovic J, Shulman J, Solle JC, Murphy K, Nuytemans K, Kieburtz K, Markopoulou K, Marek K, Levine KS, Chahine LM, Screven L, Ruffrage L, Shulman L, Marsili L, Kuhl M, Dean M, Makarious MB, Koretsky M, Inca-Martinez M, Nalls MA, Louie N, Mencacci NE, Albin R, Alcalay R, Walker R, Bandres-Ciga S, Chowdhury S, Dumanis S, Lubbe S, Xie T, Foroud T, Beach T, Sherer T, Song Y, Nguyen D, Nguyen T, Atadzhanov M. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinson's Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9). npj Parkinson's Disease 2023, 9(1), 133.

  • Reviews

    • Foltynie T, Gandhi S, Gonzalez-Robles C, Zeissler M-L, Mills G, Barker R, Carpenter J, Schrag A, Schapira A, Bandmann O, Mullin S, Duffen J, McFarthing K, Chataway J, Parmar M, Carroll C, Shlomo YB, Edwards M, Whone A, Counsell C, Clarke C, Burnell M, Salathiel D, Whipps S, Jewell A, Barber T, Weil R, Gray CW, Hu M, Rochester L, Piccini P, Zetterberg H, Noyce A, Chaudhuri R, Lawton M, Jha A, Siu C, Bartlett M, van Wamelen D, Stott S, Tofaris G, Sammler E, Mortiboys H, Wei L, Wong A, Duty S, Dexter D, Scurfield P, Jabbari E, Morris H, Breen D, Lambert C, Korlipara P, Silverdale M, Bhatia K, Yarnall A, Khengar R, Collins H, Hudson F, Baxendale G, Croucher R, Bartolomeur-Pires S, Allison J, Morgan A, Wonnacott S, Athauda D, Henderson E, Clegg S, Matthews K, Deeson E, Miller L, Handley J, Matthews H, Batla A, Bakshi N, Port B, Ellis-Doyle R, Collins SL, Rudiger J, Chapman R, Cedarbaum J, Lang A, Fiske B, Wyse R, Boxer A, Wilson D, Corvol JC, Harris J. Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease. Brain 2023, 146(7), 2717-2722.
    • Milne-Ives M, Carroll C, Meinert E. Self-management Interventions for People With Parkinson Disease: Scoping Review. Journal of Medical Internet Research 2022, 24(8), e40181.
    • van Wamelen DJ, Sringean J, Trivedi D, Carroll CB, Schrag AE, Odin P, Antonini A, Bloem BR, Bhidayasiri R, Chaudhuri KR. Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?. Parkinsonism and Related Disorders 2021, 89, 186-194.